Pliant Therapeutics Inc (PLRX) stock news · $77.3M cap
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
This PLRX news page leads with what Pliant Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for PLRX yet. We will not pad this page with generic market recap.
Latest reported PLRX revenue for 2025-12-31 was $0. Net income was -$149.3M. PLRX currently screens at market cap $77.3M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the PLRX stock page; for the tape open the quote page.
PLRX stock news FAQ
What is PLRX's latest net income?
Latest cached Pliant Therapeutics Inc (PLRX) net income was -$149.3M. Statements: https://lician.com/financials/plrx
What is PLRX's market cap?
Pliant Therapeutics Inc (PLRX) market cap is $77.3M on the latest cached fundamentals snapshot.
What kind of company is PLRX?
Pliant Therapeutics Inc (PLRX) is a biotechnology company listed on US.
Where is PLRX stock news listed?
Cached stock news for Pliant Therapeutics Inc (PLRX) is listed at https://lician.com/news/plrx. Filings: https://lician.com/sec/plrx
Not investment advice.